Diabetes

Adults who undergo bariatric surgery have a lower risk for all-cause mortality compared with those who do not undergo surgery, according to findings published in Obesity.

The FDA approved bexagliflozin, an oral SGLT2 inhibitor, to improve glycemic control for adults with type 2 diabetes, according to a company press release.

An 8-hour time-restricted eating intervention did not improve insulin sensitivity, insulin secretion or beta-cell function in a small group of adults with overweight or obesity, according to data from a randomized controlled trial.

Revised clinical practice guidelines on diabetes management in chronic kidney disease have been released by the nonprofit organization Kidney Disease: Improving Global Outcomes, or KDIGO.

Switching to intermittent-scanned continuous glucose monitors with low glucose alarms reduced hypoglycemia frequency among middle-aged adults with type 1 diabetes, researchers reported.

The Kidney Disease Improving Global Outcomes updated the clinical practice guidelines for treating patients with diabetes and chronic kidney disease to recommend new practices, according to a press release.

Effects of empagliflozin (Jardiance, Boehringer Ingelheim/Eli Lilly) on cardiac structure, function and circulating biomarkers in people with CV risk factors without diabetes.

Prior metformin use was associated with better survival rates among people with diabetes within 3 months of being hospitalized with pneumonia, a study published in Clinical Infectious Diseases found.

Consuming at least 20% of daily calories from fast food correlated with an increased risk for nonalcoholic fatty liver disease, with more damaging effects among individuals with underlying metabolic comorbidities.

Via deep learning modeling, researchers in the U.K. observed a monotonic relationship between elevated BP and CV events in patients with diabetes, and not a J-shaped relationship as observed in prior studies.